Ignite Creation Date:
2025-12-25 @ 12:18 AM
Ignite Modification Date:
2026-02-20 @ 8:15 PM
Study NCT ID:
NCT03376958
Status:
COMPLETED
Last Update Posted:
2019-07-25
First Post:
2017-10-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Apatinib for Relapsed and Refractory Diffuse Large B Cell Lymphoma
Sponsor:
Zhengzhou University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
hnslblzlzx2017-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None